The Court of Criminal Appeal held that the low quantity (marginally above the commercial quantity threshold) and low purity (less than 1%) of methylamphetamine supplied in tablet form were not mitigating factors, but rather matters to be considered in the overall sentencing exercise. The Court reaffirmed that it is inappropriate to speak of quantity and purity in terms of aggravation or mitigation, and noted that where drugs are supplied in pill form intended for direct ingestion, arguments about inability to cut or further disseminate the drug carry no weight. The Court also observed that the concurrent structuring of sentences for counts 1-3 within the sentence for count 4 gave the applicant a significant concession, such that even if error were found on count 4, restructuring would likely have produced the same overall result.
The full text is available to signed-in members, including the 3 later cases that cite this judgment.
1 of the 3 citing cases carry a classified treatment. How each court treated it is available to signed-in members.